Here are five highlights:
1. Currently, the only means to diagnose EoE is through upper endoscopy to obtain biopsies of the esophagus. This is done under general anesthesia and has to be repeated as often as three or four times a year to assess treatment response.
2. Dr. Wershil and colleagues are correlating a number of potential biomarkers with data gleaned from biopsies when participating patients undergo endoscopy. They are also evaluating how biomarker levels change over time in the same patient, especially in response to treatment.
3. The American Partnership for Eosinophilic Diseases is funding their research.
4. Ann & Robert H. Lurie Children’s Hospital of Chicago is ranked fifth in the nation in pediatric gastroenterology by the U.S. News & World Report.
5. Dr. Wershil earned his medical degree from Washington University School of Medicine in St. Louis and completed his residency at St. Louis Children’s Hospital. He completed a fellowship in pediatric gastroenterology at Boston Children’s Hospital.
More articles on GI & endoscopy:
FDA approves 1st CRC screening blood test, LifeBond’s GI-related sealant receives CE Mark & more — 7 GI company key notes
Aspirin use may lower risk of bile duct cancer: 3 observations
Nor-ursodeoxycholic acid shows success in treating primary sclerosing cholangitis — 3 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
